How many insider trades does FilingIQ track for NVAX?

FilingIQ tracks 1,366 Form 4 insider transactions for NVAX (NOVAVAX INC), covering filings from Feb 20, 2015 onwards. 54 of those were filed in the last 90 days.

Are NVAX insiders net buyers or net sellers?

Across the full Form 4 history for NVAX, 24 transactions (2%) were open-market purchases and 817 (60%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does NVAX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is NVAX in?

NOVAVAX INC (NVAX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.56B.

NVAX insider trading

NasdaqGS Healthcare

NOVAVAX INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

1,366

Last 90 days

Buys / sells

2% / 60%

Market cap

$1.56B

About NOVAVAX INC

Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Company website: www.novavax.com

NVAX insider activity at a glance

FilingIQ has scored 1,366 insider transactions for NVAX since Feb 20, 2015. The most recent filing in our index is dated Apr 25, 2026.

Across the full history, 24 open-market purchases and 817 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NVAX insider trades is 61.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live NVAX trades on FilingIQ Raw filings on SEC EDGAR

Latest NVAX Form 4 filings

Dubovsky Filip President, R&D

S Jun 17, 2024

Dubovsky Filip President, R&D

S May 14, 2024

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding NVAX

VR Adviser, LLC

$19.33M · 3.3% of AUM

Frequently asked

How many insider trades does FilingIQ track for NVAX?: FilingIQ tracks 1,366 Form 4 insider transactions for NVAX (NOVAVAX INC), covering filings from Feb 20, 2015 onwards. 54 of those were filed in the last 90 days.
Are NVAX insiders net buyers or net sellers?: Across the full Form 4 history for NVAX, 24 transactions (2%) were open-market purchases and 817 (60%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NVAX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is NVAX in?: NOVAVAX INC (NVAX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.56B.

Methodology & sources

Every NVAX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.